Hutchin Hill Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-214,401
Closed -$11.2M 762
2017
Q3
$11.2M Buy
214,401
+91,201
+74% +$5.09M 0.42% 58
2017
Q2
$7.21M Buy
123,200
+107,165
+668% +$5.57M 0.24% 96
2017
Q1
$735K Sell
16,035
-148,236
-90% -$7.38M 0.02% 542
2016
Q4
$8.64M Sell
164,271
-179,566
-52% -$8.69M 0.3% 69
2016
Q3
$15.3M Buy
+343,837
New +$14.9M 0.32% 43
2016
Q2
Sell
-97,300
Closed -$4.01M 760
2016
Q1
$4.01M Buy
+97,300
New +$4.01M 0.12% 221
2015
Q4
Sell
-56,700
Closed -$2.27M 782
2015
Q3
$2.27M Buy
56,700
+34,700
+158% +$1.52M 0.09% 280
2015
Q2
$883K Buy
+22,000
New +$759K 0.02% 494

Other funds holding SYNH

Hutchin Hill Capital's SYNH Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 214,401 shares — an estimated $11.2M sold.

Hutchin Hill Capital first reported a position in SYNH in Q2 2015 and held it in 8 quarters. The position peaked at $15.3M in Q3 2016. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 214,401 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $11.2M.
  • Hutchin Hill Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 8 quarters.
  • Hutchin Hill Capital's Syneos Health, Inc. Class A Common Stock position peaked at $15.3M in Q3 2016.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.